Sinocelltech
68852033.852.11% ( +0.70 )
Sinocelltech (688520)
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, viral inf...
- Open
- 33.20
- High
- 34.13
- Low
- 33.18
- Prev. Close
- 33.15
- Volume
- 18.01K
- Turnover
- 60.95M
- Avg Price
- 33.84
- Bid/Ask Ratio
- --
- Amplitude
- 2.87%
- 52wk High
- 78.84
- Volume Ratio
- 0.45
- Turnover Ratio
- 0.40%
Sinocelltech Analyst Rating
View MoreForecast & Rating
Apr 3, 2026Price forecast
¥55.0062.48%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · Feb 13 at 01:28 AM
02:28 ETWorld-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
- Zhitong · Aug 28, 2025 at 05:24 AM
Sinocelltech released its semi-annual performance report, with a net loss attributable to the parent company of 33.77 million yuan, turning from profit to loss year-on-year
- Zhitong · Aug 13, 2025 at 10:38 PM
Guotai Junan Securities: China's innovative drugs are in the early stage of realizing innovative achievements, optimistic about the potential emergence of the next blockbuster product in specific segments
- Zhitong · Jul 29, 2025 at 03:13 AM
Sinocelltech: SCT640C injection has received approval for clinical trials
- Zhitong · Jul 24, 2025 at 03:05 AM
Sinocelltech's subsidiary product SCT640C has received approval for clinical drug trials
- AASTOCKS · Jul 3, 2025 at 10:30 PM
The three major indices of A-shares in Shanghai and Shenzhen fluctuated upwards in the first half of the day, with bank stocks steadily rising
